Associated Papers
Molecular and immunological features of a prolonged exceptional responder with malignant pleural mesothelioma treated initially and rechallenged with pembrolizumab.
Minchom A et al.
Journal for Immunotherapy of Cancer, 2020
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
Dufva O et al.
Nature Communications, 2018
29674644 (PubMed )
Supplement: 41467_2018_3987_MOESM5_ESM.xlsx › ANKL2
Whole-genome sequencing identifies new genetic alterations in meningiomas.
Tang M et al.
Oncotarget, 2017
28177878 (PubMed )
Supplement: oncotarget-08-17070-s001.pdf
Select a paper to view details